SCHEMBL5773811

SCHEMBL5773811

COc1cccc(N2CCN(CCCc3[nH]nc4c3CCCC4)CC2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.59
DRD2 P14416 5/20 0.53
DCTPP1 Q9H773 2/20 0.52
TNKS O95271 1/20 0.52
TNKS2 Q9H2K2 1/20 0.52
HTR1A P08908 6/20 0.49
HTR7 P34969 3/20 0.48
DRD4 P21917 2/20 0.48
HTR2A P28223 2/20 0.48
HRH1 P35367 2/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2C P18825 1/20 0.48
HRH2 P25021 1/20 0.48
HTR1B P28222 1/20 0.48
ADRA1A P35348 1/20 0.48
ADRA1B P35368 1/20 0.48
HTR2B P41595 1/20 0.48
SIGMAR1 Q99720 1/20 0.48
DRD1 P21728 1/20 0.47
DRD3 P35462 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776645 0.85 KCNH2 (0.57) KCNH2HTR1AHTR7ADRA2AADRA1A
SCHEMBL5772832 0.85 SIGMAR1 (0.53) KCNH2DRD2TNKSTNKS2HTR1A
SCHEMBL5772457 0.84 SIGMAR1 (0.52) KCNH2DRD2TNKSTNKS2HTR1A
SCHEMBL5776276 0.83 SIGMAR1 (0.58) DRD2HTR1AHTR7DRD4HTR2A
SCHEMBL5774848 0.83 HTR7 (0.56) DRD2HTR1AHTR7HTR2ASIGMAR1
SCHEMBL5776684 0.82 SIGMAR1 (0.53) KCNH2DRD2HTR1AHTR7DRD4
SCHEMBL5775439 0.81 MAPT (0.45) KCNH2DRD2HTR7DRD4HRH1
SCHEMBL5777048 0.80 DRD2 (0.56) DRD2HTR1AHTR7DRD4HTR2A
SCHEMBL5774841 0.80 HTR7 (0.42) DRD2HTR1AHTR7DRD4HTR2A
SCHEMBL5775029 0.80 MAPT (0.44) KCNH2DRD2HTR7DRD4HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-B1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF MITSUBISHI PHARMA CORP (JP) 2006-11-02 EP disclosed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed